Gabapentin Tablet
Product Images NDC 71610-777

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 600 mg (71610 0777 30)

Gabapentin 600 mg oral tablets label showing quantity of 30 tablets. The label includes the NDC number 71610-0777-30 and storage instructions to keep between 20°C to 25°C. Manufactured by ScieGen Pharmaceuticals Inc. and repackaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Image 01)

A line chart depicting the mean pain score over an 8-week period comparing Gabapentin 3600 mg/day to placebo, with a 4-week dose titration period followed by a 4-week fixed dose period. The x-axis represents weeks from baseline to week 8, and the y-axis represents mean pain score from 0 to 10.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain score over time in weeks, comparing placebo and Gabapentin doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks including baseline, and the y-axis represents mean pain score. The graph illustrates changes during a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing responder rates in two studies. It shows proportions for placebo (PBO) and Gabapentin (GBP) at various dosages with percentages labeled above each bar, indicating greater response with Gabapentin doses 1800 mg, 2400 mg, and 3600 mg versus placebo.*

FDA Label Image

Image-04 (Image 04)

An equation illustration showing the formula for calculating creatinine clearance (CLCr) based on age in years, weight in kilograms, and serum creatinine in mg/dL, with a multiplier of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of the active ingredient Gabapentin, showing its molecular arrangement including a cyclohexane ring, an amino group, and a carboxylic acid group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference versus daily dose (mg) of Gabapentin across three studies labeled as Study a, Study b, and Study c. The x-axis represents daily doses from 600 mg to 1800 mg, and the y-axis shows difference percentages ranging roughly from 7% to 18%. Distinct markers are used for each study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.